Stocks and Investing
Stocks and Investing
Wed, April 6, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Derek Archila Initiated (ZNTL) at Buy and Held Target at $67 on, Apr 6th, 2022
Derek Archila of Wells Fargo, Initiated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy and Held Target at $67 on, Apr 6th, 2022.
Derek has made no other calls on ZNTL in the last 4 months.
There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Derek's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Derek
- Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $94 on, Thursday, January 20th, 2022
- Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $97 on, Friday, December 17th, 2021
Contributing Sources